Orexigen Therapeutics (OREX)

Create an Alert
6.33 -0.05  -0.78%   NASDAQ Jun 19, 5:00PM BATS Real time Currency in USD

Orexigen Therapeutics Return on Equity:

-114.9% for Dec. 31, 2012
View Full Chart

Orexigen Therapeutics Return on Equity Chart

    Orexigen Therapeutics Historical Return on Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -114.9%
    Sept. 30, 2012 -93.18%
    June 30, 2012 -59.54%
    March 31, 2012 -53.69%
    Dec. 31, 2011 -72.67%
    Sept. 30, 2011 -128.7%
    June 30, 2011 -129.1%
    March 31, 2011 -112.4%
    Dec. 31, 2010 -95.82%
    Sept. 30, 2010 -85.36%
    June 30, 2010 -91.59%
       
    March 31, 2010 -108.0%
    Dec. 31, 2009 -121.5%
    Sept. 30, 2009 -135.8%
    June 30, 2009 -150.7%
    March 31, 2009 -118.2%
    Dec. 31, 2008 -114.6%
    Sept. 30, 2008 -103.9%
    June 30, 2008 -87.58%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro

    About Return on Equity (ROE)

    Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

    ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

    Investors generally are interested in company's that have high, increasing returns on equity.
    Learn More

    Get data for

    OREX Return on Equity Benchmarks

    Companies
    Vivus -66.91%
    Arena Pharmaceuticals -86.62%
    Synergy Pharmaceuticals -178.1%

    OREX Return on Equity Rankings

    Overall 59th percentile
    6724 of 16782
    Sector 59th percentile
    577 of 1410 in Healthcare
    Industry 59th percentile
    61 of 152 in Drug Manufacturers - Specialty & Generic

    OREX Return on Equity Range, Past 5 Years

    Minimum -150.7% Jun 2009
    Maximum -53.69% Mar 2012
    Average -104.1%

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');